Integration of Biosimilars Option in the management of Lung Cancer

Description

Case Presentation: 78Y/M NSCLC â??moderately differentiated squamous cell carcinoma, keratinizing type. TNM Stage T4N2M1a group stage IVA Post 6/6 cycles of palliative chemotherapy on Carboplatin + Paclitaxel in June with RECIST Stable disease Presenting for post-chemo assessment- Issues: wasting and cachexia Didactic Presentation

Objectives

Presenters

1. Mr. Anthony Muchiri
   RCO- Oncology
   International Cancer Institute


2. Dr. David Wata
   Oncology Pharmacist
   Kenyatta National Hospital